BRITTANY SEIFERT: Open Payments
NPI 1295194132 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 62 payments from 10 companies in 2025. Trend: 2023 $809 · 2024 $734 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $245 |
| ABBVIE INC. | 17 | $222 |
| Otsuka America Pharmaceutical, Inc. | 7 | $165 |
| Vanda Pharmaceuticals Inc. | 8 | $149 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Lundbeck LLC | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Alkermes, Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, REXULTI, HETLIOZ, Auvelity, ARISTADA, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across AR — which companies pay providers there.
